10/29
09:57 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Report
Tourmaline Bio (NASDAQ:TRML) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
9/15
08:07 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $35.00.
Medium
Report
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $35.00.
9/15
06:14 am
trml
Rating for TRML
Low
Report
Rating for TRML
9/15
06:14 am
trml
Rating for TRML
Low
Report
Rating for TRML
9/14
04:05 pm
trml
Tourmaline Bio downgraded to Market Perform from Outperform at BMO Capital
Low
Report
Tourmaline Bio downgraded to Market Perform from Outperform at BMO Capital
9/14
04:05 pm
trml
Tourmaline Bio downgraded to Market Perform from Outperform at BMO Capital
Low
Report
Tourmaline Bio downgraded to Market Perform from Outperform at BMO Capital
9/10
08:49 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Guggenheim. They now have a $48.00 price target on the stock, down previously from $55.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Guggenheim. They now have a $48.00 price target on the stock, down previously from $55.00.
9/10
08:49 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Guggenheim. They now have a $48.00 price target on the stock, down previously from $55.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Guggenheim. They now have a $48.00 price target on the stock, down previously from $55.00.
9/10
08:44 am
trml
Rating for TRML
Low
Report
Rating for TRML
9/10
08:44 am
trml
Rating for TRML
Low
Report
Rating for TRML
9/10
08:00 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $48.00 price target on the stock, down previously from $70.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $48.00 price target on the stock, down previously from $70.00.
9/10
08:00 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock, down previously from $50.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock, down previously from $50.00.
9/10
06:20 am
trml
Rating for TRML
Low
Report
Rating for TRML
9/10
06:06 am
trml
Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
9/10
06:06 am
trml
Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
9/9
05:03 pm
trml
Tourmaline Bio (NASDAQ:TRML) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Low
Report
Tourmaline Bio (NASDAQ:TRML) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
9/9
05:03 pm
trml
Tourmaline Bio (NASDAQ:TRML) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Low
Report
Tourmaline Bio (NASDAQ:TRML) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
9/9
04:09 pm
trml
Tourmaline Bio downgraded to Neutral from Buy at Chardan
Low
Report
Tourmaline Bio downgraded to Neutral from Buy at Chardan
9/9
03:34 pm
trml
Rating for TRML
Low
Report
Rating for TRML
9/9
03:34 pm
trml
Rating for TRML
Low
Report
Rating for TRML
9/9
03:16 pm
trml
Tourmaline Bio downgraded to Hold from Buy at Jefferies
Low
Report
Tourmaline Bio downgraded to Hold from Buy at Jefferies
9/9
03:16 pm
trml
Tourmaline Bio downgraded to Hold from Buy at Jefferies
Low
Report
Tourmaline Bio downgraded to Hold from Buy at Jefferies
9/9
08:33 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
9/9
08:33 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
9/9
08:21 am
trml
Tourmaline Bio downgraded to Neutral from Buy at Guggenheim
Low
Report
Tourmaline Bio downgraded to Neutral from Buy at Guggenheim